IL-1-Activated Inflammatory Cardiac Fibroblasts Exacerbate Acute Coxsackievirus B3 Myocarditis

David S Elias1, Wonyoung Jo1, Monica V Talor1

  • 1Department of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Insights

Inflammatory fibroblasts (IFs) drive viral myocarditis by producing chemokines, not profibrotic genes. Targeting IL-1 signaling in these fibroblasts significantly reduces heart inflammation, offering a potential therapeutic strategy for this dangerous heart condition.

Area of Science:

  • Cardiology
  • Immunology
  • Fibroblast Biology

Background:

  • Acute viral myocarditis is a severe heart condition often triggered by viral infections like coxsackievirus B3 (CVB3).
  • The role of inflammatory fibroblasts (IFs) in the pathogenesis of viral myocarditis is not fully understood.
  • Identifying specific molecular pathways driving IF activation is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the kinetics and functional role of inflammatory fibroblasts (IFs) in acute viral myocarditis.
  • To identify key molecular signals that activate IFs during myocarditis.
  • To evaluate the therapeutic potential of targeting fibroblast-specific signaling pathways.

Main Methods:

  • Utilized CCL2-mCherry reporter mice to track IFs during CVB3-induced myocarditis.
  • Analyzed chemokine and gene expression profiles of IFs.
  • Generated and studied PDGFRαcreIL1r1fl/fl mice with fibroblast-specific deletion of IL-1 receptor signaling.
  • Examined endomyocardial biopsies from human patients.

Main Results:

  • IFs exhibited peak activity on day 3 of myocarditis, producing Th1, Th2, and Th17 chemokines.
  • Interleukin-1 beta (IL-1β) was identified as a potent activator of IFs.
  • Targeted deletion of IL-1 signaling in fibroblasts reduced cardiac inflammation by 45%, decreasing monocytes, T cells, and NK cells, without impacting viral clearance.
  • IFs were confirmed in human myocardial biopsies.

Conclusions:

  • Fibroblast-specific IL-1 signaling is a critical driver of cardiac inflammation in viral myocarditis.
  • IFs contribute to myocarditis pathogenesis through chemokine production rather than profibrotic activity.
  • Targeting fibroblast IL-1 signaling represents a promising therapeutic strategy for viral myocarditis.

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...